Ixazomib (MLN9708) in Combination With Carboplatin in Pretreated Women With Advanced Triple Negative Breast Cancer
Clinical trial NCT02993094 · TERMINATED
Trial details
- NCT number
- NCT02993094
- Sponsor
- Arbeitsgemeinschaft medikamentoese Tumortherapie
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-21
- Primary completion
- 2020-08-15
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.